Hektas Ticaret TAS (HEKTS)

Currency in TRY
4.140
-0.290(-6.55%)
Closed·
HEKTS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.0404.520
52 wk Range
2.7605.270
Key Statistics
Bid/Ask
4.14 / 4.15
Prev. Close
4.43
Open
4.47
Day's Range
4.04-4.52
52 wk Range
2.76-5.27
Volume
514.61M
Average Volume (3m)
324.57M
1-Year Change
32.2684%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HEKTS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.300
Upside
+3.86%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4.300
(+3.86% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 05, 2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
2.22B / --
EPS Revisions
Last 90 days

HEKTS Income Statement

Compare HEKTS to Peers and Sector

Metrics to compare
HEKTS
Peers
Sector
Relationship
P/E Ratio
−9.8x−7.2x3.4x
PEG Ratio
−0.210.020.00
Price/Book
2.3x1.4x1.6x
Price / LTM Sales
6.2x1.6x1.3x
Upside (Analyst Target)
3.9%35.6%35.6%
Fair Value Upside
Unlock−5.4%2.6%Unlock

Hektas Ticaret T.A.S. manufactures, imports, and markets agricultural products, fertilizers and veterinary medicines in Turkey. The company’s crop protection products include fungicides, herbicides, insecticides, acaricides, fumigants and nemathists, harvesting aids and plant growth regulators, winter struggle medicines and summer oils, spreads-adhesives, biological products, and feromons. It also offers smart base, leaf, pure, and fertilizers; organominerals; drip irrigation; biological preparation; and other plant nutrition products. In addition, the company provides ruminant, poultry, and pet products, as well as environmental health and seeds products. Hektas Ticaret T.A.S. was incorporated in 1956 and is headquartered in Gebze, Turkey.

Industry
Chemicals
Employees
547
Market
Türkiye

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
386.96M4.59%1.60B
Other Institutional Investors
4.67B55.34%19.31B
Public Companies & Retail Investors
3.38B40.07%13.98B
Total
8.43B100.00%34.9B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Ordu Yardimlasma Kurumu55.40%4,670,220,00019,334,711
BlackRock, Inc.1.59%134,137,747555,330

People Also Watch

317.00
ASTOR
-1.78%
7.21
KONTR
-8.15%
2.490
SASA
-3.86%
20.36
AEFES
-1.45%
19.230
EKGYO
-5.36%

FAQ

What Is the Hektas (HEKTS) Stock Price Today?

The Hektas stock price today is 4.140 TRY.

What Stock Exchange Does Hektas Trade On?

Hektas is listed and trades on the Istanbul Stock Exchange.

What Is the Stock Symbol for Hektas?

The stock symbol for Hektas is "HEKTS."

What Is the Hektas Market Cap?

As of today, Hektas market cap is 34.900B TRY.

What Is Hektas's Earnings Per Share (TTM)?

The Hektas EPS (TTM) is -0.421.

When Is the Next Hektas Earnings Date?

Hektas will release its next earnings report on Mar 27, 2026.

From a Technical Analysis Perspective, Is HEKTS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Hektas Stock Split?

Hektas has split 21 times.

How Many Employees Does Hektas Have?

Hektas has 547 employees.

What is the current trading status of Hektas (HEKTS)?

As of Jun 07, 2026, Hektas (HEKTS) is trading at a price of 4.140 TRY, with a previous close of 4.430 TRY. The stock has fluctuated within a day range of 4.040 TRY to 4.520 TRY, while its 52-week range spans from 2.760 TRY to 5.270 TRY.

What Is Hektas (HEKTS) Price Target According to Analysts?

The average 12-month price target for Hektas is 4.300 TRY, with a high estimate of 4.3 TRY and a low estimate of 4.3 TRY. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +3.86% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.